HOME >> MEDICINE >> NEWS
12-month study demonstrated tolerability and efficacy of Daytrana

SAN DIEGO MAY 23, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that DAYTRANATM (methylphenidate transdermal system), the first and only non-oral medication approved for treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 12 years, provided significant improvement in symptom control and tolerability, according to results of a 12-month open-label study presented at the American Psychiatric Association (APA) annual meeting in San Diego.

"We documented that children with ADHD experienced effective ADHD treatment with use of DAYTRANA for 12 months, sustaining the improvements in their ability to maintain focus and concentration," said investigator Oscar Bukstein, M.D., M.P.H ,Associate Professor of Psychiatry, University of Pittsburgh School of Medicine. "More importantly, Daytrana maintained a favorable safety profile, meeting the study's primary endpoint, and demonstrating an incidence of adverse events that is consistent with previous trials and other stimulants in this class."

Shire's DAYTRANA is the first and only patch medication approved by the U.S. Food and Drug Administration (FDA) to treat the symptoms of ADHD in children aged 6 to 12 years. DAYTRANA is available in four dosage strengths 10 mg, 15 mg, 20 mg and 30 mg all designed for once-daily use. When worn for the recommended nine hours, efficacy has been demonstrated from the first time point measured (two hours) through the 12-hour time point. Because DAYTRANA is a patch, physicians may recommend that patients shorten the wear time if shorter duration of effect is desired or to help manage the potential for late-day side effects.

Bukstein added, "DAYTRANA's novel patch delivery system offers physicians and parents of children with ADHD a convenient, non-oral option to individualize ADHD treatment to meet their children's changing schedules."

This study was an open-label extension of four clinical trials. T
'"/>

Contact: Marion E. Glick
212-601-8273
Porter Novelli
23-May-2007


Page: 1 2 3

Related medicine news :

1. $1.5 billion needed to ensure 12-month stockpile of pediatric vaccines
2. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
3. Penn study finds pro-death proteins required to regulate healthy immune function
4. New study shows promise in reducing surgical risks associated with surgical bleeding
5. New study counts the economic cost of persistent pain in Australia
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. Most seniors now have drug coverage, U-M study shows
8. To gain muscle and lose fat, drink milk: study
9. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
10. Even older women at high risk have little interest in being tested for HIV, study finds
11. Metabolic study in mice could lead to good cholesterol boosters

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/13/2019)... CHARLOTTE, N.C. (PRWEB) , ... July 12, 2019 ... ... brand (NYSE American: YCBD), has been named a “Brand to Watch” by Brightfield ... Brightfield Group ranked cbdMD in the top 10 of domestic CBD companies in ...
(Date:7/13/2019)... (PRWEB) , ... July 12, 2019 , ... The American ... Report. This report is designed to help medical aesthetic and medical spa professionals understand ... from providers across the industry. , “It’s been two years since AmSpa released the ...
(Date:7/12/2019)... ... ... Rebecca Baxt, M.D., F.A.A.D. and Saida Baxt, M.D., F.A.A.D. of BAXT CosMedical ... BAXT CosMedical is a renowned facility that believes in honest consultations and natural results ... years. , NJ Top Docs, Dr. Rebecca Baxt and Dr. Saida Baxt pride themselves ...
(Date:7/11/2019)... , ... July 11, 2019 , ... ... knowledge tools and educational resources with a range of features to further advance ... the global pharmaceutical industry in manufacturing quality medicines for patients worldwide. The latest ...
(Date:7/10/2019)... ... July 10, 2019 , ... Foggiare --the first and only ... and effective beauty and wellness technology. Developed by Sauna Italia , an Italian ... already a proven success in over 180 locations in Europe and Asia. Slim-Up is ...
Breaking Medicine News(10 mins):
(Date:7/13/2019)... ... July 12, 2019 , ... Southern California healthcare group West Medical ... overweight patients, particularly those who may not meet the standard criteria for bariatric surgery. ... reduce the available area of the stomach – and thereby reduce the appetite – ...
(Date:7/11/2019)... , ... July 11, 2019 , ... ... addition of Jaylee Hilliard, MSN, RN, NEA-BC, as a clinical advisor. Jaylee will ... joins the AngelEye Health team with more than a decade of progressive clinical ...
(Date:7/10/2019)... ... July 10, 2019 , ... Physicians for Informed Consent (PIC) ... of hundreds of its doctor and scientist members out of concern that some ... exemptions to vaccination and labeling them as “fraudulent.” , The letter explains how ...
Breaking Medicine Technology:
Cached News: